Mengying He

机构：Shanghai Medical College of Fudan University, Peking University, Wuhan University, Renmin Hospital of Wuhan University, Huashan Hospital

发表论文 58 篇 · 总被引 2148 次 · h-index 24

代表论文

Reactive oxygen species-powered cancer immunotherapy: Current status and challenges (2023 · Journal of Controlled Release · 被引 139)
Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy (2021 · Advanced Healthcare Materials · 被引 86)
Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief (2024 · Journal of Controlled Release · 被引 64)
Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy (2023 · Biomaterials · 被引 63)
Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis (2022 · Journal of the American Heart Association · 被引 45)
Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment (2022 · Chemical Engineering Journal · 被引 42)